Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Teleflex Incorporated made materially false and/or misleading statements and/or failed to disclose that: On February 27, 2025, Fierce Biotech published an article entitled "Teleflex plays musical chairs, plans company split amid €760M Biotronik cardiovascular deal." The article stated that "Teleflex has announced a plan to split its business into two separate independent companies-and it's setting up one of its future scions with a new portfolio of cardiovascular device assets, set to be acquired from Biotronik." Following this news, Teleflex's stock fell over 21% on the same day.
In order to be eligible to join the TFX class action lawsuit, you must have incurred a loss on shares of Teleflex Incorporated purchased during the class period listed above.
TOP
